【24h】

Oral methylphenidate establishes a conditioned place preference in rats.

机译:口服哌醋甲酯可在大鼠中建立条件性位置偏爱。

获取原文
获取原文并翻译 | 示例
           

摘要

Emerging data suggest that illicit methylphenidate abuse is a growing problem. Although abuse of the drug typically occurs by the intranasal route, oral (per os; p.o.) methylphenidate also has abuse potential. The present study compared the effects of p.o. and intraperitoneal (i.p.) methylphenidate in rats using the conditioned place preference (CPP) procedure. Young adult male Sprague-Dawley rats were trained to consume oyster crackers injected initially with saline. Next, rats were randomly assigned to receive p.o. or i.p. methylphenidate (3 or 10mg/kg) or saline immediately or 30min prior to 30min conditioning trials. Methylphenidate or saline were each paired 4 times with an end compartment; preference for the methylphenidate-paired compartment was then assessed on a drug-free session. When given immediately prior to conditioning, significant CPP was obtained with both 3 and 10mg/kg of i.p. methylphenidate, but only with 10mg/kg of p.o. methylphenidate. When given 30min prior to conditioning, there was no evidence of CPP for any dose of i.p. or p.o. methylphenidate. These findings are the first demonstration that p.o. methylphenidate has rewarding effects, although i.p. methylphenidate is obtained at a 3mg/kg dose which did not establish CPP with p.o. administration. The lack of CPP following 30min pretreatment also suggests that conditioning may require the CS to be associated with a US of ascending, rather than descending, brain levels of methylphenidate. These results are consistent with clinical evidence of the reduced abuse liability of p.o. methylphenidate relative to methylphenidate taken by other (e.g., intranasal) routes.
机译:新兴数据表明,滥用哌醋甲酯是一个日益严重的问题。尽管药物滥用通常通过鼻内途径发生,但口服(口服;口服)哌醋甲酯也具有滥用的可能性。本研究比较了p.o.使用条件性位置偏爱(CPP)方法在大鼠体内和腹膜内(i.p.)哌醋甲酯对成年雄性Sprague-Dawley大鼠进行训练,使其可以食用最初注入盐水的牡蛎饼干。接下来,将大鼠随机分配以接受p.o。或i.p.哌醋甲酯(3或10mg / kg)或生理盐水立即或30分钟调理试验前30分钟。哌甲酯或盐水分别与末端隔室配对4次;然后在无毒疗程中评估哌醋甲酯配对隔室的偏爱。如果在调理前立即服用,则每公斤i.p. 3和10mg / kg均可获得显着的CPP。哌醋甲酯,但仅以10mg / kg的p.o.哌醋甲酯。调理前30分钟给予任何剂量的腹膜内注射均无CPP证据。或p.o.哌醋甲酯。这些发现是p.o.尽管i.p.以3mg / kg的剂量获得哌醋甲酯,与p.o不能建立CPP。行政。预处理30分钟后CPP的缺乏还表明,调节可能需要CS与哌醋甲酯水平升高而非下降的US相关。这些结果与降低p.o滥用责任的临床证据一致。相对于通过其他(例如鼻内)途径服用的哌醋甲酯而言。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号